Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.41 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2670048 | 0.93 | CYP2D6 (0.63) | CYP2D6CYP1A2ACHECYP3A4CYP2C19 | |
| SCHEMBL6198029 | 0.93 | CYP2D6 (0.63) | CYP2D6CYP1A2ACHECYP3A4CYP2C19 | |
| SCHEMBL14778959 | 0.93 | CYP2D6 (0.59) | CYP2D6CYP1A2ACHECYP3A4CYP2C19 | |
| SCHEMBL6198035 | 0.93 | CYP2D6 (0.63) | CYP2D6CYP1A2ACHECYP3A4CYP2C19 | |
| Fluoride SCHEMBL27871310 | 0.91 | CYP2D6 (0.61) | CYP2D6CYP1A2ACHECYP3A4CYP2C19 | |
| SCHEMBL6170506 | 0.91 | CYP2D6 (0.51) | CYP2D6CYP1A2ACHECYP3A4CYP2C19 | |
| SCHEMBL777214 | 0.89 | CYP2D6 (0.63) | CYP2D6CYP1A2ACHECYP3A4CYP2C19 | |
| SCHEMBL29664915 | 0.89 | CYP2D6 (0.53) | CYP2D6CYP1A2ACHECYP3A4CYP2C19 | |
| SCHEMBL15070095 | 0.89 | CYP2D6 (0.53) | CYP2D6CYP1A2ACHECYP3A4CYP2C19 | |
| SCHEMBL4127356 | 0.89 | CYP2D6 (0.50) | CYP2D6CYP1A2ACHECYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1847568-B1 | THERMOSETTING RESIN COMPOSITION, THERMOSETTING-RESIN MOLDING MATERIAL, AND CURED OBJECT OBTAINED THEREFROM | SUMITOMO BAKELITE CO (JP) | 2015-05-20 | — | — | EP | claimed |
| WO-2024090531-A1 | CATION-CURABLE COMPOSITION | 日産化学株式会社 | 2024-05-02 | — | — | WO | disclosed |
| US-20200303086-A1 | ELECTROCONDUCTIVE FILM AND METHOD FOR MANUFACTURING ELECTROCONDUCTIVE PATTERN | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2020-09-24 | — | — | US | disclosed |
| US-10720259-B2 | Electroconductive film and method for manufacturing electroconductive pattern | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2020-07-21 | — | — | US | disclosed |
| US-20170309363-A1 | ELECTROCONDUCTIVE FILM AND METHOD FOR MANUFACTURING ELECTROCONDUCTIVE PATTERN | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2017-10-26 | — | — | US | disclosed |
| US-9304399-B2 | Resist composition and method for producing semiconductor device | SONY CORPORATION (JP) | 2016-04-05 | — | — | US | disclosed |
| US-9240614-B2 | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES, LTD. (JP) | 2016-01-19 | — | — | US | disclosed |
| EP-1847568-B1 | THERMOSETTING RESIN COMPOSITION, THERMOSETTING-RESIN MOLDING MATERIAL, AND CURED OBJECT OBTAINED THEREFROM | SUMITOMO BAKELITE CO (JP) | 2015-05-20 | — | — | EP | disclosed |
| US-20140248777-A1 | RESIST COMPOSITION AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE | SONY CORPORATION (JP) | 2014-09-04 | — | — | US | disclosed |
| EP-2579377-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES (JP) | 2014-09-03 | — | — | EP | disclosed |
| US-7595144-B2 | Sulfonate-containing anti-reflective coating forming composition for lithography | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-09-29 | — | — | US | disclosed |
| EP-1305282-B1 | PLEUROMUTILIN DERIVATIVES HAVING ANTIBACTERIAL ACTIVITY | NABRIVA THERAPEUTICS AG (AT) | 2008-09-17 | — | — | EP | disclosed |
| US-20080003524-A1 | Sulfonate-Containing Anti-Reflective Coating Forming Composition for Lithography | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2008-01-03 | — | — | US | disclosed |
| EP-1813987-A1 | SULFONIC-ESTER-CONTAINING COMPOSITION FOR FORMATION OF ANTIREFLECTION FILM FOR LITHOGRAPHY | Nissan Chemical Industries, Ltd. (JP) | 2007-08-01 | — | — | EP | disclosed |
| US-6913867-B2 | Negative photosensitive resin composition, negative photosensitive dry film and method of forming pattern | KANSAI PAINT CO., LTD. (JP) | 2005-07-05 | — | — | US | disclosed |
| US-6753445-B2 | 14-O-((CYCLOALKYL-SULFANYL)ACETYL)-, 14-O-((CYCLOALKYL-ALKYL-SULFANYL)ACETYL)-, 14-O-((CYCLOALKOXY)ACETYL)- AND 14-O-((CYCLOALKYL-ALKOXY) ACETYL) MUTILINS; MICROBIOCIDES | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 2004-06-22 | — | — | US | disclosed |
| US-20030162831-A1 | Pleuromutilin derivatives having antibacterial activity | Nabriva Therapeutics GmbH (AT) | 2003-08-28 | — | — | US | disclosed |
| EP-1305282-A1 | PLEUROMUTILIN DERIVATIVES HAVING ANTIBACTERIAL ACTIVITY | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 2003-05-02 | — | — | EP | disclosed |
| US-20020068237-A1 | Negative photosensitive resin composition, negative photosensitive dry film and method of forming pattern | KANSAI PAINT CO., LTD. (JP) | 2002-06-06 | — | — | US | disclosed |
| WO-2002004414-A1 | PLEUROMUTILIN DERIVATIVES HAVING ANTIBACTERIAL ACTIVITY | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 2002-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162831-A1 | Pleuromutilin derivatives having antibacterial activity | MLN, PLEC, ST14 | CYP2D6 3132/4885CYP1A2 3555/4885ACHE 1038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.